Instil Bio
TIL • NASDAQ
Instil Bio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bronson Crouch, with a market cap of $52.8M.
CEOBronson Crouch
Next Earnings
Upcoming earnings announcement for Instil Bio
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.60
Earnings History
Past 12 earnings reports for Instil Bio
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | Q4 2025 | -$0.97Est: -$3.19 | +69.6% | - | — |  10-K |
| Nov 13, 2025 | Q3 2025 | -$1.75Est: -$2.62 | +33.2% | - | — | 10-Q |
| Aug 13, 2025 | Q2 2025 | -$2.88Est: -$2.15 | -34.0% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$1.32Est: -$3.68 | +64.1% | - | — | 10-Q |
| Mar 4, 2025 | Q4 2024 | -$1.08Est: -$3.65 | +70.4% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$2.55Est: -$2.10 | -21.4% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$2.29Est: -$2.98 | +23.2% | - | — | 10-Q |
| May 10, 2024 | Q1 2024 | -$2.39Est: -$2.23 | -7.2% | - | — | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$1.26Est: -$2.85 | +55.8% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$3.20Est: -$2.00 | -60.0% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$2.20Est: -$3.20 | +31.3% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$8.80Est: -$3.00 | -193.3% | - | — | — |